Clinical Trial

Open Label Optimization Study

Study acronym: OLO
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to demonstrate effectiveness in the treatment of Major Depressive Disorder The primary objective is to assess the effectiveness in the treatment of Major Depressive Disorder using the CGI-I at the end of the treatment Participants will receive 10 treatments per day for 5 days (M-F) of SAINT®
Protocol Amendment History 17 amendments
This ClinicalTrials.gov record has been amended 17 times since 2023-04-17; most recent amendment 2025-12-18.
Status change: Recruiting → Active, Not Recruiting 2025-06-30
Status change: Not Yet Recruiting → Recruiting 2023-04-26
Trial Details
NCT Number NCT05819021
Lead Sponsor Magnus Medical
Conditions Major Depressive Disorder
Enrollment 1,000 participants
Start Date 2023-04-06
Primary Completion 2026-10-15 (estimated)
Study Completion 2027-04-15 (estimated)
Updated on ClinicalTrials.gov 2025-12-24